Omega Therapeutics (OMGA) Revenue & Revenue Breakdown
Omega Therapeutics Revenue Highlights
Latest Revenue (Y)
$3.09M
Latest Revenue (Q)
$2.61M
Omega Therapeutics Revenue by Period
Omega Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $3.09M | 49.25% |
2022-12-31 | $2.07M | 1339.58% |
2021-12-31 | $144.00K | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Omega Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $2.61M | 22.40% |
2024-06-30 | $2.13M | -9.58% |
2024-03-31 | $2.36M | 138.62% |
2023-12-31 | $989.00K | 19.01% |
2023-09-30 | $831.00K | 9.49% |
2023-06-30 | $759.00K | 47.09% |
2023-03-31 | $516.00K | -29.80% |
2022-12-31 | $735.00K | 23.53% |
2022-09-30 | $595.00K | 25.00% |
2022-06-30 | $476.00K | 77.61% |
2022-03-31 | $268.00K | 86.11% |
2021-12-31 | $144.00K | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Omega Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CNTA | Centessa Pharmaceuticals | $6.88M | - |
OMGA | Omega Therapeutics | $3.09M | $2.61M |
OBIO | Orchestra BioMed | $2.76M | $778.00K |
MNOV | MediciNova | $1.00M | - |
GPCR | Structure Therapeutics | - | - |
PHVS | Pharvaris | - | - |
AVTE | Aerovate Therapeutics | - | - |
OLMA | Olema Pharmaceuticals | - | - |
CVKD | Cadrenal Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
LRMR | Larimar Therapeutics | - | - |
NVCT | Nuvectis Pharma | - | - |
ELVN | Enliven Therapeutics | - | - |
CMPX | Compass Therapeutics | - | - |
MLTX | MoonLake Immunotherapeutics | - | - |
PEPG | PepGen | - | - |